Orion Portfolio Solutions’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $3.04M | Buy |
27,518
+1,615
| +6% | +$179K | 0.03% | 525 |
|
|
2024
Q4 | $3.54M | Sell |
25,903
-1,031
| -4% | -$141K | 0.04% | 435 |
|
|
2024
Q3 | $3.1M | Sell |
26,934
-221
| -0.8% | -$25.5K | 0.03% | 487 |
|
|
2024
Q2 | $3.74M | Sell |
27,155
-1,810
| -6% | -$249K | 0.04% | 399 |
|
|
2024
Q1 | $3.99M | Sell |
28,965
-490
| -2% | -$67.6K | 0.04% | 379 |
|
|
2023
Q4 | $3.95M | Sell |
29,455
-2,749
| -9% | -$368K | 0.05% | 365 |
|
|
2023
Q3 | $3.62M | Buy |
32,204
+3,993
| +14% | +$449K | 0.04% | 381 |
|
|
2023
Q2 | $15.3M | Sell |
28,211
-3,559
| -11% | -$1.93M | 0.16% | 125 |
|
|
2023
Q1 | $3.22M | Buy |
+31,770
| New | +$3.22M | 0.04% | 403 |
|
|
2020
Q3 | – | Sell |
-34
| Closed | -$4K | – | 1464 |
|
|
2020
Q2 | $4K | Buy |
34
+3
| +10% | +$353 | ﹤0.01% | 1568 |
|
|
2020
Q1 | $3K | Buy |
31
+6
| +24% | +$581 | ﹤0.01% | 1474 |
|
|
2019
Q4 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 1422 |
|